Gastonia, North Carolina Clinical Trials

A listing of Gastonia, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 41 clinical trials
A Study to Assess the Efficacy Safety and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

The primary objective of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period.

USA033
 (3.8 away) Contact site
  • 3 views
  • 01 Aug, 2021
  • +258 other locations
Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 2b adaptive dose-finding study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Clinical Research of Gastonia
 (4.9 away) Contact site
  • 0 views
  • 19 Jul, 2021
  • +132 other locations
A Study of TAK-994 in Adults With Narcolepsy

Adults with narcolepsy who have completed the TAK-994-1501 study will be able to take part in this study. The main aim of this study is to check if participants have side effects from TAK-994. Participants will take one of 3 different TAK-994 dose for 8 weeks. Then, half the participants …

Clinical Research of Gastonia,
 (3.8 away) Contact site
  • 8 views
  • 07 Jul, 2021
  • +151 other locations
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

solid tumors
platelet count
bevacizumab
oxaliplatin
adjuvant therapy
CaroMont Regional Medical Center
 (4.9 away) Contact site
  • 72 views
  • 27 Jul, 2021
  • +978 other locations
An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy

The rationale for the interventional, open-label, single-arm design of JZP258-401 is to evaluate the clinical experience in participants with narcolepsy transitioning treatment from Xyrem to XYWAV.

stimulant
xyrem
Clinical Research of Gastonia
 (4.9 away) Contact site
  • 0 views
  • 16 Jul, 2021
  • +18 other locations
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

This is a Phase 2/3 study that comprises 5 substudies designed to evaluate the efficacy, safety, and tolerability of oral etrasimod as therapy in adult participants with moderately to severely active Crohn's disease (CD) who are refractory or intolerant to at least 1 of the current therapies for CD (ie, …

certolizumab pegol
adalimumab
budesonide
tumor necrosis factor alpha
corticosteroids
Clinical Research of Gastonia
 (4.9 away) Contact site
  • 63 views
  • 22 Jul, 2021
  • +157 other locations
Efficacy & Safety of TD-1473 in Ulcerative Colitis

A Phase 2b/3 set of studies to evaluate the efficacy and safety of induction and maintenance therapy with TD-1473 in subjects with moderately-to-severely active ulcerative colitis with up to 60 weeks of treatment.

aminosalicylates
corticosteroids
immunomodulators
Theravance Biopharma Investigational Site
 (4.9 away) Contact site
  • 75 views
  • 28 Jan, 2021
  • +202 other locations
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

This randomized phase III trial studies how well olanzapine with or without fosaprepitant work in preventing chemotherapy induced nausea and vomiting in cancer patients receiving chemotherapy that causes vomiting. Olanzapine and fosaprepitant dimeglumine may help control nausea and vomiting in patients during chemotherapy. Olanzapine is usually given in combination with …

emetics
diabetes
metastasis
vomiting
nausea
CaroMont Regional Medical Center
 (4.9 away) Contact site
  • 109 views
  • 29 Jul, 2021
  • +603 other locations
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (300/L). Eligible patients must have a history of 2 moderate and/or severe COPD exacerbations in the previous year …

eosinophil count
antibiotics
bronchodilator
corticosteroids
severe chronic obstructive pulmonary disease
Research Site
 (3.8 away) Contact site
  • 838 views
  • 04 Aug, 2021
  • +426 other locations
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

The purpose of this open-label extension (OLE) study is to evaluate the safety and efficacy of etrasimod in participants with moderately to severely active ulcerative colitis (UC) who previously received double-blinded treatment (either etrasimod 2 mg per day or placebo) during participation in one of two Phase 3 double-blinded, placebo-controlled …

Clinical Research of Gastonia
 (4.9 away) Contact site
  • 133 views
  • 04 Aug, 2021
  • +391 other locations